Skip to main content
Log in

Japan PMDA's investigation results for five products

  • News item
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Notes

  1. PMDA = Pharmaceuticals and Medical Devices Agency

References

  1. Pharmaceuticals and Medical Devices Agency of Japan. Summary of investigation results - Aripiprazole, Aripiprazole hydrate. Internet Document : [2 pages], 11 Jan 2018. Available from: URL: http://www.pmda.go.jp/files/000222150.pdf.

  2. Pharmaceuticals and Medical Devices Agency of Japan. Summary of investigation results - Teriparatide preparations. Internet Document : [2 pages], 11 Jan 2018. Available from: URL: http://www.pmda.go.jp/files/000222152.pdf.

  3. Pharmaceuticals and Medical Devices Agency of Japan. Summary of investigation results - Edoxaban tosilate hydrate. Internet Document : [2 pages], 11 Jan 2018. Available from: URL: http://www.pmda.go.jp/files/000222156.pdf.

  4. Pharmaceuticals and Medical Devices Agency of Japan. Summary of investigation results - Ipilimumab (genetical recombination). Internet Document : [1 page], 11 Jan 2018. Available from: URL: http://www.pmda.go.jp/files/000222158.pdf.

  5. Pharmaceuticals and Medical Devices Agency of Japan. Summary of investigation results - Lenvatinib mesilate. Internet Document : [1 page], 11 Jan 2018. Available from: URL: http://www.pmda.go.jp/files/000222160.pdf.

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Japan PMDA's investigation results for five products. Reactions Weekly 1686, 5 (2018). https://doi.org/10.1007/s40278-018-41069-7

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-018-41069-7

Navigation